A Real-World Comparison of Clinical Effectiveness in Patients with Rheumatoid Arthritis Treated with Upadacitinib, Tumor Necrosis Factor Inhibitors, and Other Advanced Therapies After Switching from an Initial Tumor Necrosis Factor Inhibitor (Advances in Therapy, 2024)

(untitled) - Caporali, R; Kadakia, A; Howell, O; Patel, J; Milligan, J; Strengholt, S; Barlow, S; Taylor, PC